Ayala Pharmaceuticals Inc (ADXS)

[mypekeispooped]

I can't help but feel that DOC may have been asking far too much for a deal with mostly pre-clinical and early data. I remember he once said this could be a $50 company in a few years (which he NEVER should have said) so perhaps that clouded his judgement and he had never been a CEO before, I believe. Ken seems to have more business sense so, until we get more (better?) data, we'll be in a holding pattern.